PMC:7228307 / 54094-54263
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1110 | 42-49 | Gene | denotes | FcγRIIb | Gene:2213 |
1111 | 70-74 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T913 | 25-27 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T914 | 42-44 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T915 | 59-69 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activating |
T916 | 70-72 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
1110 | 42-49 | Gene | denotes | FcγRIIb | Gene:2213 |
1111 | 70-74 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T308 | 0-169 | Sentence | denotes | Preferential or specific Fc engagement of FcγRIIb over the activating FcγR offers several potential therapeutic advantages for new mAbs in distinct therapeutic settings. |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T308 | 0-169 | Sentence | denotes | Preferential or specific Fc engagement of FcγRIIb over the activating FcγR offers several potential therapeutic advantages for new mAbs in distinct therapeutic settings. |